Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -84.564\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
[a] CC(C)Oc1cccc(C(=O)N/N=C/c2ccoc2)c1
[b] CCc1ccc2c(CN3CCN(Cc4ccccc4)CC3)cc(=O)oc2c1
[c] O=C(NCCc1ccc(Cl)cc1)C12CC3CC(CC(O)(C3)C1)C2
[d] Nc1nccc(-c2ccc(OCc3c(F)cccc3Cl)cc2)n1
Answer: b. CCc1ccc2c(CN3CCN(Cc4ccccc4)CC3)cc(=O)oc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1ccc2c(CN3CCN(Cc4ccccc4)CC3)cc(=O)oc2c1
CCc1ccc2c(CN3CCN(Cc4ccccc4)CC3)cc(=O)oc2c1
4-[(4-benzylpiperazin-1-yl)methyl]-7-ethylchromen-2-one